Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Kymera Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +5 vs. Q2 2021
- Shares held
- 34.6M
- +8.09M (+30.5%) vs. Q2 2021
- Total value
- $2.04B
- +$746.9M (+58.0%) vs. Q2 2021
- New holders
- 21
- 63 more added
- Sold out
- 16
- 22 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Avidity Partners Management LP | 514,500 | $30.2M | 0.77% | +514,500 | New |
| Driehaus Capital Management LLC | 583,192 | $34.3M | 0.41% | +551,611+1,746.7% | Added |
| Geode Capital Management, LLC | 599,870 | $35.2M | 0.00% | +258,328+75.6% | Added |
| Deer IX & Co. Ltd. | 615,895 | $36.2M | 3.72% | −619,413−50.1% | Reduced |
| AJU IB Investment Co., Ltd. | 639,059 | $37.5M | 24.22% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 732,927 | $43.1M | 0.91% | +106,400+17.0% | Added |
| State Street Corp | 1,439,776 | $84.6M | 0.00% | +103,130+7.7% | Added |
| FMR LLC | 2,355,807 | $138.4M | 0.01% | +173,378+7.9% | Added |
| Baker Bros. Advisors LP | 2,384,742 | $140.1M | 0.62% | +425,531+21.7% | Added |
| Wellington Management Group LLP | 2,467,935 | $145.0M | 0.02% | +1,639,994+198.1% | Added |
| Redmile Group, LLC | 2,793,708 | $164.1M | 2.86% | +262,200+10.4% | Added |
| Vanguard Group Inc | 2,901,574 | $170.4M | 0.00% | +857,350+41.9% | Added |
| BlackRock Inc. | 3,040,431 | $178.6M | 0.01% | +591,914+24.2% | Added |
| BVF Inc | 3,180,658 | $186.8M | 7.29% | +550,000+20.9% | Added |
| Price T Rowe Associates Inc | 3,233,197 | $189.9M | 0.02% | +1,388,271+75.2% | Added |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −519,416−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −479,605−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −278,127−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −119,761−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −48,460−100.0% | Sold out |
| Islet Management, LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −18,587−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −16,301−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,143−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −6,144−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,085−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,512−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |